US2023264003A1PendingUtilityA1
Method and apparatus for delivering a drug
Assignee: GREMILLION GRAYSON MATTHEWPriority: Sep 14, 2016Filed: Sep 26, 2022Published: Aug 24, 2023
Est. expirySep 14, 2036(~10.1 yrs left)· nominal 20-yr term from priority
Inventors:Grayson Matthew Gremillion
A61M 31/002A61M 5/31A61M 2210/0618A61M 37/0069A61M 5/178A61K 9/0024
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In the specification and drawings a method and apparatus for delivering a drug into a nasal turbinate or nasal polyp is described and shown, which can include implanting a drug eluting implant into a nasal turbinate or nasal polyp; and leaving the drug eluting material in the nasal turbinate or nasal polyp for at least one day such that a drug is released from the drug eluting implant over a period of time.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method for delivering a drug into nasal tissue comprising:
a) placing a drug eluting implant into a needle of a syringe; b) inserting the needle at an anterior end of a nasal turbinate; c) inserting the needle into a submucosal plane of the turbinate; d) implanting the drug eluting implant into the submucosal plane of the turbinate; and e) withdrawing the needle from the turbinate.
2 . The method of claim 1 wherein said placing a drug eluting implant into a needle of a syringe further comprises placing a slow release poly(lactic-co-glycolic acid) scaffold into the needle of the syringe.
3 . The method of claim 1 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises implanting a slow release poly(lactic-co-glycolic acid) scaffold into the submucosal plane of the turbinate.
4 . The method of claim 1 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises depressing a plunger of the syringe such that an ejector connected to the plunger ejects the drug eluting implant into the submucosal plane of the turbinate.
5 . The method of claim 4 further comprising simultaneously performing said depressing a plunger of the syringe such that an ejector connected to the plunger ejects the drug eluting implant into the submucosal plane of the turbinate and said withdrawing the needle from the turbinate.
6 . The method of claim 1 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises implanting the drug eluting implant into an inferior turbinate.
7 . The method of claim 1 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises implanting a steroid eluting implant into the submucosal plane of the turbinate.
8 . The method of claim 1 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises implanting an antihistamine eluting implant into the submucosal plane of the turbinate.
9 . The method of claim 8 wherein said implanting the drug eluting implant into the submucosal plane of the turbinate further comprises implanting a steroid eluting implant into the submucosal plane of the turbinate.
10 . The method of claim 1 further comprising leaving the drug eluting implant in the submucosal plane of the turbinate for at least one day.
11 . A method for delivering a drug into nasal tissue comprising:
a) placing a drug eluting implant into a needle of a syringe; b) inserting the needle into a nasal polyp; c) implanting the drug eluting implant into the nasal polyp; and d) withdrawing the needle from the nasal polyp.
12 . The method of claim 11 wherein said placing a drug eluting implant into a needle of a syringe further comprises placing a slow release poly(lactic-co-glycolic acid) scaffold into the needle of the syringe.
13 . The method of claim 11 wherein said implanting the drug eluting implant into the nasal polyp further comprises implanting a slow release poly(lactic-co-glycolic acid) scaffold into the nasal polyp.
14 . The method of claim 11 wherein said implanting the drug eluting implant into the nasal polyp further comprises depressing a plunger of the syringe such that an ejector connected to the plunger ejects the drug eluting implant into the nasal polyp.
15 . The method of claim 14 further comprising simultaneously performing said depressing a plunger of the syringe such that an ejector connected to the plunger ejects the drug eluting implant into the nasal polyp and said withdrawing the needle from the nasal polyp.
16 . The method of claim 11 wherein said implanting the drug eluting implant into the nasal polyp further comprises implanting a steroid eluting implant into the nasal polyp.
17 . The method of claim 11 wherein said implanting the drug eluting implant into the nasal polyp further comprises implanting an antihistamine eluting implant into the nasal polyp.
18 . The method of claim 17 wherein said implanting the drug eluting implant into the nasal polyp further comprises implanting a steroid eluting implant into the nasal polyp.
19 . The method of claim 11 further comprising leaving the drug eluting implant in the nasal polyp for at least one day.
20 . A method for delivering a drug into nasal tissue comprising:
a) implanting a drug eluting material into a nasal turbinate; and b) leaving the drug eluting material in the nasal turbinate for at least one day.
21 . A method for delivering a drug into nasal tissue comprising:
a) implanting a drug eluting material into a nasal polyp; and b) leaving the drug eluting material in the nasal polyp for at least one day.Join the waitlist — get patent alerts
Track US2023264003A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.